Introduction
============

The marked reduction of transmissible diseases with the introduction of antibiotics, vaccines, the decline of mortality in the acute phase of diseases and the improvement of living standards have determined not only the increase of life expectancy but also the prevalence of chronic diseases \[[@b1-cm-87-102]\]. Nowadays chronic diseases affect over 80% of the population over 65 years. If in 2006 the elderly represented 8% of the world population, by 2030 it is expected to rise to 13%, with the biggest increase rate in developing countries \[[@b2-cm-87-102]\]. Also, an increase is estimated in the "oldest-old" segment, people over 80 years, by 151% between 2005--2030 \[[@b2-cm-87-102],[@b3-cm-87-102]\]. Chronic diseases are often comorbidities in elderly patients, affecting the functionality and the quality of life and increasing the costs of long-term care \[[@b4-cm-87-102],[@b5-cm-87-102],[@b6-cm-87-102]\]. A great share has dementia \[[@b7-cm-87-102],[@b8-cm-87-102],[@b9-cm-87-102]\], together with chronic pulmonary diseases, diabetes, cardiovascular diseases, locomotion, genitourinary infections and neurodegenerative diseases \[[@b10-cm-87-102],[@b11-cm-87-102]\].

According to the Alzheimer's Disease International Report of 2013, it is estimated that over 35 million people worldwide have dementia \[[@b2-cm-87-102]\] and it is expected that this number will double in 2030 and more than treble in 2050 to 115 mil. \[[@b2-cm-87-102]\]. Between 2010 and 2015, the total number of dependent people worldwide will double from 349 mil. to 613 mil. and the number of elderly people that need care will treble from 101 mil. to 277 mil. \[[@b2-cm-87-102]\].

In 2010 the costs of dementia care were over 600 billion US dollars, representing 1% of world gross product \[[@b4-cm-87-102],[@b12-cm-87-102]\].

In this context, the study of comorbidities and chronic diseases represents not only a public health problem but also a permanent challenge for the clinical practice \[[@b13-cm-87-102]\].

Materials and methods
=====================

The study group is represented by the hospitalized population at the County Emergency Clinical Hospital-Brasov, geriatrics department, between 2011--2013: 213 patients were included in the study. Patients with neoplasia or terminally ill were excluded. For the evaluation of the number and degree of severity of comorbidities we used the Miller and co. CIRS-G scale (Cumulative Illness Scale in Geriatric population) of 1991 \[[@b14-cm-87-102],[@b15-cm-87-102],[@b16-cm-87-102]\]. To evaluate the functionality we used the IADL scale (Lawton and Brody scale). We determined the prevalence of the types of dementia; new cases of dementia were diagnosed accordingly to the diagnostic standards \[[@b17-cm-87-102],[@b18-cm-87-102],[@b19-cm-87-102]\]. The CIRS-G scale is organized in 14 disease categories by systems and represents the comorbidities: heart, vascular, hematopoietic (cells and blood vessels, bone marrow, spleen, lymphatic nodes), respiratory (lungs, bronchi, trachea), sensory organs (eyes, ears, nose, throat, larynx), upper digestive tract (esophagus, stomach, duodenum), lower digestive tract (intestine), liver (biliary duct and pancreas), renal (kidneys), genitourinary (urethra, urinary bladder, ureters, prostate, genital (womb, ovaries), musculoskeletal/integument (bones, muscles and skin), neurological (brain, spinal cord and nerves), endocrine/metabolic and breast (plus infections and intoxications), psychiatric diseases. The degrees of severity were noted from 0--4 for every item according to the degree of gravity: 0-no problem; 1-current mild problem or past significant problem; 2-moderate disability or morbidity/requires "first line" therapy; 3-severe/constant significant disability/"uncontrollable" chronic problems; 4-extremely severe/immediate treatment required/end organ failure/severe impairment in function. We evaluated the number of diseases registered, the total CIRS-G score, the severity index (total score/total number of categories endorsed), the number of categories at level 3 severity and the number of categories at level 4 severity.

IADL-instrumental activities of daily living grid organized as: ability to use the telephone, shopping, cooking, housekeeping, clothes washing, transportation, taking medication, managing money.

Results and discussion
======================

In this study 213 patients were included, 149 women and 65 men, age between 50 and 96 years (mean age 75.52±8.77). The group was divided into two groups: patients with dementia-71 (33.33%) and patients without dementia-142 (66.66%).

We identified three types of dementia: Alzheimer's Disease-42 (59.15%), mixed dementia-14 (19.71%), vascular dementia-15 (21.12%) \[[@b20-cm-87-102],[@b21-cm-87-102]\]; Alzheimer's Disease represents more than 50% of the types of dementia, its prevalence rising with age. A high dementia prevalence in women was observed (61.97%).

The most frequent comorbidities in the study group were cardiac and vascular (99.53%), metabolic diseases (94.36%), locomotion (92.01%), sensory organs (91.54%), genitourinary diseases (87.32%) and psychiatric illnesses (79.34%).

The highest severity index according to the CIRS-G scale was for the psychiatric diseases (2.13) for patients with dementia, followed by vascular (2.01) and cardiac diseases (1.93) in the whole group. The highest degree of severity for the cardiac and vascular diseases was 3, while for psychiatric diseases it was 4 in the group with dementia.

The IADL scores were lower for the patients with dementia (78.87% were dependent), the most affected domains being taking medication, using the telephone, managing money and transportation.

Conclusions
===========

In accordance with the studies published in literature we observed a high prevalence of multiple pathology in our study group too. The most frequent comorbidities were cardiac and vascular diseases, followed by psychiatric diseases, metabolic, locomotion and sensory organs diseases. Atherosclerosis is one the main causes, the clinical manifestations being visible in the heart, blood vessels, brain, kidneys and small intestine, with the known consequences. The highest medium score of severity was represented by the psychiatric disease for the patients with dementia. The severity index for vascular diseases (2.01) was higher in group with dementia. Alzheimer's disease represented over 50% of the types of dementia in the study group, the highest prevalence being in the female group (63.63%). Quantifying the functional capacities is an important component of geriatric evaluation of the chronic patients. Functional decline was visible in both groups, but with a higher prevalence in the group with dementia. Cognitive impairment -- dementia is a major factor that contributes to the functional dependency and disabilities in the elderly. Dementia represents a current public health problem due to its increasing incidence and prevalence, its powerful disabling character, long-term evolution (sometimes decades); for recovery great efforts and a long time are needed. It affects the individual, family and even the community \[[@b2-cm-87-102],[@b3-cm-87-102]\]. Evaluating the comorbidities and the degree of functionality in patients with chronic diseases may contribute to improving their quality of life. Organizing geriatric services, self-management, community services accessible to patients and their care-givers can diminish the negative impact on the individual and its family. Population ageing and the increase of chronic diseases prevalence are factors that challenge any health system regardless of its financial resources \[[@b22-cm-87-102]\].
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###### 

Distribution of comorbidities in whole group

                                           No. cases   Percent (%)
  ---------------------------------------- ----------- -------------
  Heart                                    212         99.53
  Vascular                                 212         99.53
  Hematopoietic                            65          30.51
  Respiratory                              81          38.02
  Eyes, ears, nose and throat and larynx   195         91.54
  Upper GI                                 164         76.99
  Lower GI                                 135         63.38
  Liver                                    81          38.02
  Renal                                    112         52.58
  Genitourinary                            186         87.32
  Musculoskeletal/integument               196         92.01
  Neurological                             99          46.47
  Endocrine/metabolic and breast           201         94.36
  Psychiatric disease                      169         79.34

###### 

Distribution of comorbidities in the group with dementia

                                           No. cases   Percent (%)
  ---------------------------------------- ----------- -------------
  Heart                                    71          100
  Vascular                                 71          100
  Hematopoietic                            24          33.80
  Respiratory                              30          42.25
  Eyes, ears, nose and throat and larynx   70          98.59
  Upper GI                                 56          78.87
  Lower GI                                 53          74.64
  Liver                                    15          21.12
  Renal                                    36          50.70
  Genitourinary                            68          95.77
  Musculoskeletal/integument               67          94.36
  Neurological                             47          66.19
  Endocrine/metabolic and breast           68          95.77
  Psychiatric disease                      66          92.95

###### 

Severity index for whole group

                                           Mean   Std. Deviation (±)
  ---------------------------------------- ------ --------------------
  Heart                                    1.93   0.51
  Vascular                                 2.01   0.33
  Hematopoietic                            0.47   0.77
  Respiratory                              0.68   0.99
  Eyes, ears, nose and throat and larynx   1.18   0.64
  Upper GI                                 1.11   0.75
  Lower GI                                 0.91   0.87
  Liver                                    0.57   0.82
  Renal                                    0.67   0.74
  Genitourinary                            1.53   0.85
  Musculoskeletal/integument               1.85   0.81
  Neurological                             0.83   1.10
  Endocrine/metabolic and breast           1.87   0.58
  Psychiatric disease                      1.51   0.98

###### 

Severity index for group with dementia

                                           Mean   Std. Deviation (±)
  ---------------------------------------- ------ --------------------
  Heart                                    1.85   0.06
  Vascular                                 2.04   0.03
  Hematopoietic                            0.49   0.09
  Respiratory                              0.70   0.11
  Eyes, ears, nose and throat and larynx   1.32   0.08
  Upper GI                                 1.04   0.08
  Lower GI                                 1.21   0.12
  Liver                                    0.27   0.07
  Renal                                    0.58   0.07
  Genitourinary                            1.85   0.11
  Musculoskeletal/integument               2.01   0.10
  Neurological                             1.30   0.15
  Endocrine/metabolic and breast           1.86   0.07
  Psychiatric disease                      2.13   0.11
